Vehicle Gel
Vehicle Gel is a pharmaceutical drug with 60 clinical trials. Currently 3 active trials ongoing. Historical success rate of 90.4%.
Success Metrics
Based on 47 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
26
Mid Stage
28
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.5%
47 of 55 finished
14.5%
8 ended early
3
trials recruiting
60
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.
CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea
NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)
A Study of GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer
Eyelid Androgen Treatment in Dry Eye
Clinical Trials (60)
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.
CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea
NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)
A Study of GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer
Eyelid Androgen Treatment in Dry Eye
Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up
A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp
Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up
Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up
Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris
Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up
Transient Receptor Potential Channels
A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis
Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos
Phase 3 Study to Evaluate the Safety and Efficacy of Galnobax® in Treating Diabetic Foot Ulcers
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne
P3 Study in Acne Comparing Once Daily SB204 and Vehicle
Study of the Efficacy and Safety of Granexin® Gel to Improve Burn Wound Healing
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 60